OtherBasic Science (Animal or Phantoms)
Open Access
PET imaging of PARP expression using [18F]olaparib
Thomas Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha Hopkins, Sheena Wallington, Danny Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Veronique Gouverneur and Bart Cornelissen
Journal of Nuclear Medicine November 2018, jnumed.118.213223; DOI: https://doi.org/10.2967/jnumed.118.213223
Thomas Wilson
1 University of Oxford, United Kingdom;
Mary-Ann Xavier
1 University of Oxford, United Kingdom;
James Knight
1 University of Oxford, United Kingdom;
Stefan Verhoog
1 University of Oxford, United Kingdom;
Julia Baguña Torres
1 University of Oxford, United Kingdom;
Michael Mosley
1 University of Oxford, United Kingdom;
Samantha Hopkins
1 University of Oxford, United Kingdom;
Sheena Wallington
1 University of Oxford, United Kingdom;
Danny Allen
1 University of Oxford, United Kingdom;
Veerle Kersemans
1 University of Oxford, United Kingdom;
Rebekka Hueting
2 CRUK/MRC Oxford Institute for Radiation Oncology, United Kingdom;
Sean Smart
1 University of Oxford, United Kingdom;
Veronique Gouverneur
3 University of Oxford, United Kingdom
Bart Cornelissen
1 University of Oxford, United Kingdom;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
PET imaging of PARP expression using [18F]olaparib
Thomas Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha Hopkins, Sheena Wallington, Danny Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Veronique Gouverneur, Bart Cornelissen
Journal of Nuclear Medicine Nov 2018, jnumed.118.213223; DOI: 10.2967/jnumed.118.213223
PET imaging of PARP expression using [18F]olaparib
Thomas Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha Hopkins, Sheena Wallington, Danny Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Veronique Gouverneur, Bart Cornelissen
Journal of Nuclear Medicine Nov 2018, jnumed.118.213223; DOI: 10.2967/jnumed.118.213223
Jump to section
Related Articles
Cited By...
- [123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
- [18F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy Response
- Molecular Imaging: PARP-1 and Beyond
- PARP Inhibitors in Cancer Diagnosis and Therapy
- Preclinical and first-in-human-brain-cancer applications of [18F]poly-(ADP-ribose) polymerase inhibitor PET/MR
- Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
- PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer
- Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer